#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dementia Alpha-1 antitrypsin deficiency Mucopolysaccharidosis I X-linked lymphoproliferative syndrome Ewing's sarcoma Diabetes insipidus Non-Hodgkin's lymphoma unspecified histology indolent Cutaneous T-cell lymphoma recurrent Cutaneous calcification Familial dilated cardiomyopathy Neurotrophic keratopathy Factor IX deficiency Li-Fraumeni syndrome Restless legs syndrome Chronic graft versus host disease in intestine More trials…

    Learn about Rare Diseases

    Biotinidase deficiency Shprintzen-Goldberg syndrome – Treatment Splenic marginal zone lymphoma – Basic Information Idiopathic pulmonary fibrosis Glomerulonephritis membranoproliferative – Treatment Atypical haemolytic uraemic syndrome – Treatment Vascular malformation – Life with Disease Mitochondrial myopathy – Trials in Disease Paraneoplastic neurological syndrome – Basic Information Wolfram syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gemtuzumab Ozogamicin Minocycline Dexamethasone Acetate Ph. Eur. Nitric Oxide Cimetidine Hydrochloride Cetirizine Lolium Perenne Pollen Extract Bi 764532 Filgotinib Cefepime Hydrochloride Ethambutol Tecaginlimab Sertraline Epacadostat Vortioxetine Ixazomib Citrate Ivermectin Avatrombopag Vincristine Sulfate Setrusumab More therapies…

    Learn about Your Condition

    Tourette's disorder Juvenile spondyloarthritis Gallbladder cancer Mitral valve disease Hypomagnesaemia Bronchopulmonary dysplasia Anogenital warts Glioblastoma Erdheim-Chester disease Crigler-Najjar syndrome Myocardial ischaemia Pyelonephritis acute Loeys-Dietz syndrome Idiopathic pulmonary fibrosis Palmoplantar pustulosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Axatilimab compared to standard therapy in children with chronic graft-versus-host disease who have previously received at least 2 treatments

    Recruiting

    2 1 1
    Investigated Drugs:
    • Axatilimab
    Belgium Germany Italy Spain

  • Title: Evaluating low-dose prednisone with standard therapy to improve heart function in patients with cardiac manifestations of Fabry disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Prednisone
    Poland

  • A study of drug combination (clopidogrel, acetylsalicylic acid, atorvastatin, rosuvastatin) for patients with covert brain infarction

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Atorvastatin
    • Clopidogrel
    Denmark Norway Sweden

  • Study of cangrelor and acetylsalicylic acid in patients with ischemic stroke requiring emergency carotid artery stenting and mechanical thrombectomy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    Austria

  • Study of AGP100 Safety and Effectiveness in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ventricular tachycardia
    Norway

  • Study of anifrolumab safety in adults with primary antiphospholipid syndrome (APS)

    Recruiting

    2 1 1
    Investigated Drugs:
    • Anifrolumab
    Greece
Previous Page
1 … 119 120 121 122 123 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!